Literature DB >> 12821619

The cost of major comorbidity in people with diabetes mellitus.

Scot H Simpson1, Paula Corabian, Philip Jacobs, Jeffrey A Johnson.   

Abstract

BACKGROUND: People with diabetes mellitus are more likely to have cardiovascular, renal and ophthalmic comorbidity than those without diabetes. Information on the economic impact of diabetes and its complications on the Canadian health care system is limited.
METHODS: To estimate health care expenditures for diabetes and its major complications, we identified people with diabetes in 1996 in Saskatchewan, using the administrative databases of Saskatchewan Health. We grouped utilization and expenditure data for prescription drugs, physician services, hospitalizations, day surgery procedures and dialysis services according to cardiovascular, renal and ophthalmic services, according to billing codes and the American Hospital Formulary Services classification for prescription drugs.
RESULTS: Of the 38 124 people identified (48.5% female and 9.7% registered Indians), 46.6% had cardiovascular-related records, 19.8% ophthalmic-related records and 6.6% renal-related records. Registered Indians had significantly fewer (p < 0.001) cardiovascular-related records than the rest of the diabetic population (35.1% v. 47.9%, respectively) but more renal- related records (11.7% v. 6.0%, respectively). The total 1996 Saskatchewan Health expenditure for the study group, within the observed categories, was estimated to be $134.3 million, of which $35.5 million (26.4%) was for cardiovascular-related services, $10 million (7.5%) for renal-related services and $3.3 million (2.5%) for ophthalmic-related services.
INTERPRETATION: In 1996, 36.4% of health care expenditures for people with diabetes was attributable to major comorbidity. Actions to prevent or control such comorbidity will yield significant cost savings.

Entities:  

Mesh:

Year:  2003        PMID: 12821619      PMCID: PMC161611     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  36 in total

1.  Implications of the diabetes control and complications trial.

Authors: 
Journal:  Diabetes Care       Date:  2003-01       Impact factor: 19.112

2.  Cost-effectiveness of alternative approaches in treating severely mentally ill in California.

Authors:  T W Hu; J Jerrell
Journal:  Schizophr Bull       Date:  1991       Impact factor: 9.306

3.  The cost-effectiveness of treating all patients with type 2 diabetes with angiotensin-converting enzyme inhibitors.

Authors:  L Golan; J D Birkmeyer; H G Welch
Journal:  Ann Intern Med       Date:  1999-11-02       Impact factor: 25.391

4.  The economic costs of non-insulin-dependent diabetes mellitus.

Authors:  D M Huse; G Oster; A R Killen; M J Lacey; G A Colditz
Journal:  JAMA       Date:  1989-11-17       Impact factor: 56.272

5.  Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients.

Authors:  M Shichiri; H Kishikawa; Y Ohkubo; N Wake
Journal:  Diabetes Care       Date:  2000-04       Impact factor: 19.112

6.  Mortality rates in diabetic patients from a community-based population compared to local age/sex matched controls.

Authors:  W Gatling; S Tufail; M A Mullee; T A Westacott; R D Hill
Journal:  Diabet Med       Date:  1997-04       Impact factor: 4.359

7.  Cost of care for individuals with cystic fibrosis: a regression approach to determining the impact of recombinant human DNase.

Authors:  J A Johnson; M A Connolly; P Jacobs; M Montgomery; N E Brown; P Zuberbuhler
Journal:  Pharmacotherapy       Date:  1999-10       Impact factor: 4.705

8.  Angiotensin-converting enzyme inhibition in diabetic nephropathy: ten years' experience.

Authors:  H H Parving; P Rossing; E Hommel; U M Smidt
Journal:  Am J Kidney Dis       Date:  1995-07       Impact factor: 8.860

9.  Clustering of heart disease risk factors in diabetic compared to nondiabetic adults.

Authors:  D L Wingard; E Barrett-Connor; M H Criqui; L Suarez
Journal:  Am J Epidemiol       Date:  1983-01       Impact factor: 4.897

10.  The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus.

Authors:  P Reichard; B Y Nilsson; U Rosenqvist
Journal:  N Engl J Med       Date:  1993-07-29       Impact factor: 91.245

View more
  30 in total

1.  Enrolment in primary care networks: impact on outcomes and processes of care for patients with diabetes.

Authors:  Braden J Manns; Marcello Tonelli; Jianguo Zhang; David J T Campbell; Peter Sargious; Bharati Ayyalasomayajula; Fiona Clement; Jeffrey A Johnson; Andreas Laupacis; Richard Lewanczuk; Kerry McBrien; Brenda R Hemmelgarn
Journal:  CMAJ       Date:  2011-12-05       Impact factor: 8.262

2.  Trends in postacute myocardial infarction management and mortality in patients with diabetes. A population-based study from 1995 to 2001.

Authors:  Najwa Ouhoummane; Belkacem Abdous; Rabia Louchini; Louis Rochette; Paul Poirier
Journal:  Can J Cardiol       Date:  2010-12       Impact factor: 5.223

3.  Health-related quality of life deficits associated with diabetes and comorbidities in a Canadian National Population Health Survey.

Authors:  Sheri L Maddigan; David H Feeny; Jeffrey A Johnson
Journal:  Qual Life Res       Date:  2005-06       Impact factor: 4.147

4.  Health-related behaviours in adults with diabetes: associations with health care utilization and costs.

Authors:  Ronald C Plotnikoff; Nandini D Karunamuni; Jeffrey A Johnson; Maria Kotovych; Lawrence W Svenson
Journal:  Can J Public Health       Date:  2008 May-Jun

5.  Canadian residential schools and urban indigenous knowledge production about diabetes.

Authors:  Heather A Howard
Journal:  Med Anthropol       Date:  2014

6.  The cost of diabetes in Canada over 10 years: applying attributable health care costs to a diabetes incidence prediction model.

Authors:  Anja Bilandzic; Laura Rosella
Journal:  Health Promot Chronic Dis Prev Can       Date:  2017-02       Impact factor: 3.240

7.  Use of chronic disease management programs for diabetes: in Alberta's primary care networks.

Authors:  David J T Campbell; Peter Sargious; Richard Lewanczuk; Kerry McBrien; Marcello Tonelli; Brenda Hemmelgarn; Braden Manns
Journal:  Can Fam Physician       Date:  2013-02       Impact factor: 3.275

8.  Lifetime risk of diabetes among First Nations and non-First Nations people.

Authors:  Tanvir Chowdhury Turin; Nathalie Saad; Min Jun; Marcello Tonelli; Zhihai Ma; Cheryl Carmelle Marie Barnabe; Braden Manns; Brenda Hemmelgarn
Journal:  CMAJ       Date:  2016-09-19       Impact factor: 8.262

9.  Identifying strategies to improve diabetes care in Alberta, Canada, using the knowledge-to-action cycle.

Authors:  Braden Manns; Ted Braun; Alun Edwards; Jeremy Grimshaw; Brenda Hemmelgarn; Don Husereau; Noah Ivers; Jeff Johnson; Steve Long; Kerry McBrien; Christopher Naugler; Peter Sargious; Sharon Straus; Marcello Tonelli; Andrea C Tricco; Catherine Yu
Journal:  CMAJ Open       Date:  2013-11-20

10.  The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: a retrospective cross-sectional study using a national pharmacy claims database.

Authors:  Miriam O'Shea; Mary Teeling; Kathleen Bennett
Journal:  BMC Health Serv Res       Date:  2013-01-16       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.